Botulinum toxin – indications still to be explored
-
Upload
amita-jain -
Category
Education
-
view
383 -
download
0
description
Transcript of Botulinum toxin – indications still to be explored
Dr. Amita Jain Consultant UrogynaecologistMedanta Institute of Kidney & Urology Medanta -The MedicityGurgaon, Haryana -122001, INDIA
Irreversible binding to the presynaptic membrane, producing a long-lasting paralytic effect.
Action dose- and site-specific, may take 24–48 hrs to exert its effects.
Dr Amita Jain Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
Neuropathic bladder conditions◦ Detrusor overactivity
◦ Detrusor sphincter dysenergia
Bladder overactivity Painful bladder syndrome Pelvic pain Outflow obstruction symptoms Urinary retention
Intradetrusor injection of BTx was approved in 2011 by FDA for neurogenic detrusor overactivity only, but the off-label use is increasingly common.
Dr Amita Jain Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
9 ½ Years girlK/C of Langerhan’s Histocytosis ( on & off steroids)PRESENTING COMPLAINTS (March 2009) Recurrent UTI Nocturnal Enuresis Daytime incontinence Difficulty in passing urinePAST H/O Gross haematuria in 2009 (USG KUB / CECT - mild diffuse thickening of
bladder wall ?Cystitis) CPE +urethral dilatation in 2010 (DMSA/ DRCG/KFT – WNL) Protenuria suggestive of ? Ig A Nephropathy/ Nephrotic SyndromePHYSICAL EXAMINATION Normal
Dr Amita Jain Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
Micturating cystourethrogram (2010)- no reflux, no urethral obstruction
MRI Spine - normal
USG KUB - B/L mild HUN, persisting post void Thickened & irregular bladder wall PVR 126 cc
Failed trial of antimuscarinics & alpha blockers, biofeedback and other conservative management.
Dr Amita Jain Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
Dr Amita Jain Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
Sensation Bladder filling
Pdet
First sensation
21 cc -2 cmH2O
First desire 48 cc 29 cmH2O
Normal desire
70 cc 43 cmH2O
Strong desire 91 cc 159 cmH2O
Max cyst capacity
91 cc 158 cmH2O
Total bladder capacity 180 cc
Voided volume 71 cc
Peak flow rate 3 ml/s
Pdet at peak flow 8 cmH2O
Average flow rate 3 ml/s
Residual Urine 109 ml
Opening Pdet 12 cmH2O
Dr Amita Jain Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
Refractory idiopathic detrusor overactivity with superimposed dysfunctional voiding (non-neuropathic bladder-sphincter dysfunction )
Dr Amita Jain Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
Sensation Bladder filling
Pdet
First sensation
42 cc 7 cmH2O
First desire 84 cc 14 cmH2O
Normal desire 88 cc 16 cmH2O
Strong desire 110 cc 32 cmH2O
Max cyst capacity
110 cc 33 cmH2O
Total bladder capacity 110 cc
Voided volume 73 cc
Peak flow rate 6 ml/s
Pdet at peak flow 33 cmH2O
Average flow rate 3 ml/s
Residual Urine 37 ml
Opening Pdet 24 cmH2O
Dr Amita Jain Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
48 years librarianK/C of Interstitial Cystitis Dx on Cystoscopy + bladder biopsy (2/8/10) PRESENTING COMPLAINTS (May 2011) Severe dysuria Frequent urination Feeling of incomplete emptying of bladder Poor flowsPAST H/O Urethral dilatation in 2000 Failed conservative ( lifestyle & diet modification), medical
management (Amitryptalline/PMSO) and Intravesical instillation therapies
Dr Amita Jain Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
Sensation Bladder filling
Pdet
First sensation 59 cc 2 cmH2O
First desire 65 cc 2 cmH2O
Normal desire 79 cc 2 cmH2O
Strong desire 88 cc 3 cmH2O
Max cyst capacity
104 cc 5 cmH2O
Total bladder capacity 106 cc
Voided volume 55 cc
Peak flow rate 3 ml/s
Pdet at peak flow 19 cmH2O
Average flow rate 2 ml/s
Residual Urine 51 ml
Opening Pdet 15 cmH2O
Dr Amita Jain Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
Painful bladder Syndrome/IC(hypersensitive low capacity bladder)
Dr Amita Jain Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
Dr Amita Jain Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
200 units diluted with 20mls of normal saline
Given as 1 ml injections at 20 different sites including trigone*
Fig. 1. Injection technique for BoNT into the overactive bladderDae Kyung Kim et al Urol Clin N Am 33 (2006) 503-510
*Kuo HC (2011) Bladder base/trigone injection is safe and as effective as bladder body injection of onabotulinumtoxinA for idiopathic detrusor overactivity refractory to antimuscarinics. Neurourol Urodyn 30:1242–1248*Pinto R et al (2010) Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. Eur Urol. Sep;58(3):360-5
Dr Amita Jain Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
Dr Amita Jain Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
Minor effects (Karsenty et al, 2008)◦ most frequent◦ injection site pain◦ procedure-related urinary tract infection◦ mild hematuria◦ Increase in PVR Severe effects (Systemic)◦ Very rare◦ Drug reaction - rash of a flu- like illness◦ Nausea, vomitting◦ dysphagia, diplopia, blurred vision◦ Mouth & respiratory weakness◦ periheral muscle weakness Contraindications◦ pre-existing neuromuscular conditions
Dr Amita Jain Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
Linda Brubaker et al (2012) Treatment satisfaction and goal attainment with onabotulinumtoxinA in patients with incontinence due to idiopathic OAB Int Urogynecol J 23:1017–1025
Denys P et al (2012) Efficacy and Safety of Low Doses of OnabotulinumtoxinA for the Treatment of Refractory Idiopathic Overactive Bladder: A Multicentre, Double-Blind, Randomised, Placebo-Controlled Dose-Ranging Study. Eur Urol 61:520–529
Rovner E et al (2011) Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxin A in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder. Neurourol Urodyn 30:556–562
Duthie JB et al (2011) Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev (12):CD005493
Dmochowski R et al (2010) Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial. J Urol 184:2416–2422
Dr Amita Jain Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
Shiu-Dong Chung et al (2012) Intravesical OnabotulinumtoxinA Injections for Refractory Painful Bladder Syndrome. Pain Physician; 15:197-202 • ISSN 1533-3159
Giannantoni A et al (2008) Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup. J Urol ; 179:1031- 1034.
Giannantoni A et al(2006) Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: A pilot study. Eur Urol ; 49:704-709.
Dr Amita Jain Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
No universally accepted dose and technique.
Exact targeted depth of injection remains controversial.
Promising alternative option for varied indications in future.
Thanks
Dr Amita Jain Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
Dr. Amita JainUrogynaecology Clinic
12th Floor, OPD Wing,Medanta -The Medicity
Gurgaon, Haryana -122001, INDIATel: +91 124 4141 414 [email protected] www.medanta.org
MOB. +91-9871136110 http://www.urogynecologistindia.in/
http://amitajainurogynaecolgist.blogspot.in/http://www.linkedin.com/mbox?displayMBoxItem=&itemID=I225857003_75
Medanta Institute of Kidney & Urology